Repco Home Finance Q2FY27: PAT up 8.6% YoY, but AUM growth of 9.2% trails 13-14% guidance
PAT +8.6% YoY · revenue +8.1% · margins flat
₹477.75 Cr
+8.1% YoY
₹119.09 Cr
+8.6% YoY
24.93%
+0.1pp YoY
₹19.04
Repco Home Finance's consolidated PAT rose 8.6% YoY to ₹119.09 Cr (₹109.66 Cr a year ago) on total income of ₹477.75 Cr, up 8.1% YoY — revenue and profit grew in step, with no exceptional items on either side of the comparison, so the reported and adjusted growth are the same. Sequentially, PAT slipped 2.1% QoQ from ₹121.62 Cr and the net profit margin eased to ~24.9% from 25.99% in Q1FY27, even though it is marginally better than the 24.82% margin a year ago — a modest QoQ softening rather than a YoY trend change, and one the limited newspaper-extract format (no interest-expense or spread breakup disclosed) doesn't let us attribute to a specific cost line. Standalone tracked consolidated closely (PAT ₹115.86 Cr, +8.3% YoY), so there is no material standalone-consolidated divergence to flag. Consolidated basic EPS was ₹19.04 versus ₹17.53 a year ago and ₹19.44 in Q1FY27.
Q2 FY-2027 vs prior quarters
Against management's own FY27 guidance from the Q1 concall — ₹5,000 Cr disbursements, 13-14% AUM growth, and a ₹40 Cr NPA reduction — this quarter is a mixed read. The company's own disclosure this week put loan book growth at 9.2% YoY to ₹16,425 Cr, running below the 13-14% AUM growth management had guided to, even as the P&L itself grew at a similar high-single-digit pace. Disbursement and NPA figures aren't broken out in this condensed extract, so those guidance checkpoints remain unverified pending the full results; management's cost-of-funds comfort (8.3%, aided by a ₹600 Cr NHB refinance line flagged last quarter) isn't testable here either given the margin line isn't disclosed. No analyst consensus or brokerage preview specifically for this Q2FY27 print turned up in a web search, so the result can't be benchmarked against the Street; broader FY27 PAT estimates (e.g., Motilal Oswal) were last revised up modestly off Q1 numbers, but that predates this print. No management press release was available to cross-check the company's own framing of the quarter.
The stock went into the print at ₹325.1, down 4.3% over the past month of trading.
For context: revenue is at a 6-quarter high.
FY2027 disbursement ₹5,000 Cr; AUM growth 13-14%; NPA reduction ₹40 Cr; Q2 target ₹1,200-1,250 Cr disbursements. Spread compression expected 10-12 bps; cost of funds stable at 8.3% aided by ₹600 Cr NHB refinance.
— This quarter: missed
The board that approved these results also considered an interim dividend (per the Nov 5 meeting notice), following a ₹3 final dividend declared in September and a board-approved increase in the borrowing limit to ₹20,000 Cr alongside plans to raise ₹1,500 Cr via NCDs and ₹1,000 Cr via CPs — all consistent with a lender scaling its balance sheet to fund growth. Two ESG upgrades (CRISIL, SES ESG at 71.70) and the appointment of joint statutory auditors for three years round out the quarter's non-P&L developments but don't bear directly on this print.
W1
AUM growth gap: 9.2% YoY loan book growth vs management's 13-14% FY27 guidance — watch if Q3 closes the gap toward the ₹5,000 Cr FY27 disbursement target
W2
NPA reduction target of ₹40 Cr flagged in the Q1 concall — not disclosed in this extract; check full results for asset-quality detail
W3
Margin trajectory: NPM eased to 24.9% from 25.99% QoQ — watch if the ₹600 Cr NHB refinance and 8.3% cost-of-funds guidance stabilize spreads next quarter
Newspaper-clipping extract (BSE Reg.33 format) discloses only Total Income from Operations with no other-income/expense split; totalExpenses and tax are derived as totalIncome−PBT and PBT−PAT. No exceptional/extraordinary items in either period — the 'before' and 'after exceptional items' PBT rows are identical for both the current and comparative columns.
Informational and educational content only. Not investment advice.